ClinicalTrials.gg
Not yet recruitingNCT05945004Updated Jul 14, 2023

ChatGPT v.s. Human in Writing a Preoperative Visit Sheet

An observational study in Preoperative Care, sponsored by Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-07-14.

Sponsored by Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2023, 3 years 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
120
Sex
All
01

Study summary

The goal of this study is to evaluate the performance of large language models i.e. ChatGPT, in making preoperative visit sheets using clinical records. The main questions it aims to answer are:

  • Can large language models read clinical records and make preoperative visit sheets same as physicians?
  • Can physicians distinguish preoperative visit sheets made by physicians and models?

Participants' records will be generated using ChatGPT-4, and read by both ChatGPT-4 and physicians to make 2 separate preoperative visit sheets, and form 2 groups, GPT group and physician group respectively.

A group of professionals will compare result of above mentioned 2 groups to see if ChatGPT can afford to write preoperative visit sheets.

02

Conditions studied

  • Preoperative Care
03

In context

Lead sponsor

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

No restictions are applied to population.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any as records are generated using ChatGPT-4.

Exclusion criteria

Exclusion Criteria:

  • Any as records are generated using ChatGPT-4.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Experiment

    Other: ChatGPT-4

  • Control

    Other: Clinician

Interventions

  • OtherChatGPT-4

    Subjects' clinical records will be read by ChatGPT-4 to write preoperative visit sheets.

  • OtherClinician

    Subjects' clinical records will be read by clinicians to write preoperative visit sheets.

06

What researchers measure

Primary outcomes

  1. Familiarity to human writing

    Based on professionals' subjective evaluation, familiarity is a binary result indicating weather professionals think the preoperative visit sheet was written by physicians or ChatGPT, where 0 indicates "not written by human" and 1 indicates "written by human".

    Time frame: Each record will be screened for 6 minutes at most and results will be given in 8 minutes after receiving a record.

  2. Satisfaction for clinical use

    A grading score of 1-10 indicating weather the professionals think the preoperative visit sheet is suitable in clinical use.

    Time frame: Each record will be screened for 6 minutes at most and results will be given in 8 minutes after receiving a record.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2023; primary completion for Aug 2023, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2023
First posted
Jul 14, 2023
StartEst.
Aug 1, 2023
Primary completionEst.
Aug 15, 2023
CompletionEst.
Sep 1, 2023
Last update
Jul 14, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05945004
Lead sponsor
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Collaborators
Tsinghua University
Responsible party
Sponsor
First posted
Jul 14, 2023
Start date
Aug 1, 2023 (estimated)
Primary completion
Aug 15, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Jul 14, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion